| The company operates an EMI qualifying share option scheme for the employees of the company. As at the statement of financial position date, the company had granted 278,838 EMI qualifying share options to 19 employees with an average weighted exercise price of £0.31 per share (2021: £0.31). At the statement of financial position date, 278,838 share options had vested (2021: 223,146). Of the vested options, none had been exercised (2021: Nil) and 111,263 had lapsed (2021: 62,894). Share options generally vest 48 months from the date of grant with some vesting 24 months from the date of grant and some fully vesting on the grant date. The share options are exercisable on the company's Ordinary shares. An amount of £18,805 has been charged to the income statement in respect of the above scheme (2021: £41,903).
The company also operates an unapproved share option scheme for employees and advisers of the company. As at the statement of financial position date, the company had granted 169,867 unapproved options to 17 employees and advisers with an average weighted exercise price of £0.46 per share (2021: £0.46). At the statement of financial position date 139,867 share options had vested (2021: 98,982). Of the vested options none had been exercised (2021: Nil) and 28,308 had lapsed (2021: 11,701). Share options generally vest 48 months from the date of grant with some vesting 24 months from the date of grant and some fully vesting on the grant date. The share options are exercisable on the company's Ordinary shares. An amount of £nil has been charged to the income statement in respect of the above scheme (2021: £1,508). |